Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2002 1
2004 1
2005 1
2006 2
2007 1
2008 7
2009 5
2010 8
2011 5
2012 6
2013 1
2014 6
2015 9
2016 4
2017 9
2018 22
2019 8
2020 14
2021 18
2022 10
2023 11
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
Reducing the Impact of Headache and Allodynia Score in Chronic Migraine: An Exploratory Analysis from the Real-World Effectiveness of Anti-CGRP Monoclonal Antibodies Compared to Onabotulinum Toxin A (RAMO) Study.
Montisano DA, Giossi R, Canella M, Altamura C, Marcosano M, Vernieri F, Raggi A, Grazzi L. Montisano DA, et al. Among authors: grazzi l. Toxins (Basel). 2024 Apr 7;16(4):178. doi: 10.3390/toxins16040178. Toxins (Basel). 2024. PMID: 38668603 Free PMC article.
Social cognition abilities in patients with primary and secondary chronic pain.
Telesca A, Vergallito A, Consonni M, Mattavelli G, Ferrario A, Grazzi L, Usai S, Romero Lauro LJ. Telesca A, et al. Among authors: grazzi l. Front Psychol. 2024 Feb 27;15:1315682. doi: 10.3389/fpsyg.2024.1315682. eCollection 2024. Front Psychol. 2024. PMID: 38596340 Free PMC article.
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
Barbanti P, Aurilia C, Egeo G, Proietti S, D'Onofrio F, Torelli P, Aguggia M, Bertuzzo D, Finocchi C, Trimboli M, Cevoli S, Fiorentini G, Orlando B, Zucco M, Di Clemente L, Cetta I, Colombo B, di Poggio MLB, Favoni V, Grazzi L, Salerno A, Carnevale A, Robotti M, Frediani F, Altamura C, Filippi M, Vernieri F, Bonassi S; Italian Migraine Registry study group. Barbanti P, et al. Among authors: grazzi l. J Neurol. 2024 May;271(5):2444-2445. doi: 10.1007/s00415-024-12287-3. J Neurol. 2024. PMID: 38564057 Free PMC article. No abstract available.
Management of medication overuse headache.
D'Amico D, Grazzi L, Tepper SJ. D'Amico D, et al. Among authors: grazzi l. Handb Clin Neurol. 2024;199:277-299. doi: 10.1016/B978-0-12-823357-3.00026-4. Handb Clin Neurol. 2024. PMID: 38307652 Review.
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
Barbanti P, Aurilia C, Egeo G, Proietti S, D'Onofrio F, Torelli P, Aguggia M, Bertuzzo D, Finocchi C, Trimboli M, Cevoli S, Fiorentini G, Orlando B, Zucco M, Di Clemente L, Cetta I, Colombo B, di Poggio MLB, Favoni V, Grazzi L, Salerno A, Carnevale A, Robotti M, Frediani F, Altamura C, Filippi M, Vernieri F, Bonassi S; ERT; for the Italian Migraine Registry study group. Barbanti P, et al. Among authors: grazzi l. J Neurol. 2024 May;271(5):2434-2443. doi: 10.1007/s00415-023-12103-4. Epub 2024 Jan 17. J Neurol. 2024. PMID: 38231271 Free PMC article.
The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders.
Leonardi M, Martelletti P, Burstein R, Fornari A, Grazzi L, Guekht A, Lipton RB, Mitsikostas DD, Olesen J, Owolabi MO, Ruiz De la Torre E, Sacco S, Steiner TJ, Surya N, Takeshima T, Tassorelli C, Wang SJ, Wijeratne T, Yu S, Raggi A. Leonardi M, et al. Among authors: grazzi l. J Headache Pain. 2024 Jan 4;25(1):4. doi: 10.1186/s10194-023-01700-3. J Headache Pain. 2024. PMID: 38178049 Free PMC article. Review.
Gender-related stress factors and emotional perception in migraine: a structured online questionnaire in migraine patients and controls.
Delussi M, Piraino G, Guerzoni S, Castro FL, Sances G, Guaschino E, Vaghi G, Grazzi L, Sacco S, Onofri A, Paparella G, Prudenzano MP, Roca ME, Fallacara A, Cevoli S, Pierangeli G, Sarchielli P, Bellotti A, Invitto S, de Tommaso M. Delussi M, et al. Among authors: grazzi l. Neurol Sci. 2024 Apr;45(4):1645-1654. doi: 10.1007/s10072-023-07152-6. Epub 2023 Nov 7. Neurol Sci. 2024. PMID: 37936018 Free PMC article.
Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030.
Martelletti P, Leonardi M, Ashina M, Burstein R, Cho SJ, Charway-Felli A, Dodick DW, Gil-Gouveia R, Grazzi L, Lampl C, MaassenVanDenBrink A, Minen MT, Mitsikostas DD, Olesen J, Owolabi MO, Reuter U, Ruiz de la Torre E, Sacco S, Schwedt TJ, Serafini G, Surya N, Tassorelli C, Wang SJ, Wang Y, Wijeratne T, Raggi A. Martelletti P, et al. Among authors: grazzi l. J Headache Pain. 2023 Oct 27;24(1):140. doi: 10.1186/s10194-023-01666-2. J Headache Pain. 2023. PMID: 37884869 Free PMC article. Review.
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN).
Filippi M, Messina R, Bartezaghi M, Cetta I, Colombo B, Grazzi L, Martinelli D, Ornello R, Pichiecchio A, Raimondi D, Russo A, Sacco S, Splendiani A, Tassorelli C, Turrini R, Valsasina P, Rocca MA; RESET BRAIN Study Group. Filippi M, et al. Among authors: grazzi l. J Neurol. 2023 Nov;270(11):5600-5612. doi: 10.1007/s00415-023-11879-9. Epub 2023 Aug 8. J Neurol. 2023. PMID: 37550498 Free PMC article. Clinical Trial.
148 results